CorMedix Inc. | Ownership
Companies that own CorMedix Inc.
Elliott Management Corp.
4,166,868
4.26%
0
0.01%
06/30/2018
The Vanguard Group, Inc.
1,772,419
1.81%
-17,886
0%
06/30/2018
BlackRock Fund Advisors
559,381
0.56%
1,424
0%
06/30/2018
Geode Capital Management LLC
295,008
0.3%
0
0%
06/30/2018
K2/D&S Management Co. LLC
223,254
0.23%
15,891
0.05%
06/30/2018
Virtu Financial BD LLC
187,952
0.19%
187,952
0.01%
06/30/2018
Planning Directions, Inc.
107,409
0.11%
0
0.06%
06/30/2018
Northern Trust Investments, Inc.
63,401
0.07%
0
0%
06/30/2018
Steward Partners Investment Advisory LLC
51,090
0.05%
2,500
0%
06/30/2018
HighTower Advisors LLC
47,188
0.05%
0
0%
06/30/2018
| Address |
400 Connell Drive
Berkeley Heights New Jersey 07921
United States
|
|
Employees
|
- |
| Website |
http://www.cormedix.com |
| Updated |
07/08/2019 |
| CorMedix, Inc. operates as a pharmaceutical and medical device company that seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The firm is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. |
